IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-33076-4.html
   My bibliography  Save this article

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland

Author

Listed:
  • Gudmundur L. Norddahl

    (deCODE genetics/Amgen, Inc.)

  • Pall Melsted

    (deCODE genetics/Amgen, Inc.
    University of Iceland)

  • Kristbjorg Gunnarsdottir

    (deCODE genetics/Amgen, Inc.)

  • Gisli H. Halldorsson

    (deCODE genetics/Amgen, Inc.)

  • Thorunn A. Olafsdottir

    (deCODE genetics/Amgen, Inc.)

  • Arnaldur Gylfason

    (deCODE genetics/Amgen, Inc.)

  • Mar Kristjansson

    (Landspitali—The National University Hospital of Iceland)

  • Olafur T. Magnusson

    (deCODE genetics/Amgen, Inc.)

  • Patrick Sulem

    (deCODE genetics/Amgen, Inc.)

  • Daniel F. Gudbjartsson

    (deCODE genetics/Amgen, Inc.
    University of Iceland)

  • Unnur Thorsteinsdottir

    (deCODE genetics/Amgen, Inc.
    University of Iceland)

  • Ingileif Jonsdottir

    (deCODE genetics/Amgen, Inc.
    University of Iceland)

  • Kari Stefansson

    (deCODE genetics/Amgen, Inc.
    University of Iceland)

Abstract

By the end of July 2021, the majority of the Icelandic population had received vaccination against COVID-19. In mid-July a wave of SARS-CoV-2 infections, dominated by the Delta variant, spread through the population, followed by an Omicron wave in December. A booster vaccination campaign was initiated to curb the spread of the virus. We estimate the risk of infection for different vaccine combinations using vaccination data from 276,028 persons and 963,557 qPCR tests for 277,687 persons. We measure anti-Spike-RBD antibody levels and ACE2-Spike binding inhibitory activity in 371 persons who received one of four recommended vaccination schedules with or without an mRNA vaccine booster. Overall, we find different antibody levels and inhibitory activity in recommended vaccination schedules, reflected in the observed risk of SARS-CoV-2 infections. We observe an increased protection following mRNA boosters, against both Omicron and Delta variant infections, although BNT162b2 boosters provide greater protection against Omicron than mRNA-1273 boosters.

Suggested Citation

  • Gudmundur L. Norddahl & Pall Melsted & Kristbjorg Gunnarsdottir & Gisli H. Halldorsson & Thorunn A. Olafsdottir & Arnaldur Gylfason & Mar Kristjansson & Olafur T. Magnusson & Patrick Sulem & Daniel F., 2022. "Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33076-4
    DOI: 10.1038/s41467-022-33076-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-33076-4
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-33076-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Bruno Pozzetto & Vincent Legros & Sophia Djebali & Véronique Barateau & Nicolas Guibert & Marine Villard & Loïc Peyrot & Omran Allatif & Jean-Baptiste Fassier & Amélie Massardier-Pilonchéry & Karen Br, 2021. "Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination," Nature, Nature, vol. 600(7890), pages 701-706, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Verena Klemis & Tina Schmidt & David Schub & Janine Mihm & Stefanie Marx & Amina Abu-Omar & Laura Ziegler & Franziska Hielscher & Candida Guckelmus & Rebecca Urschel & Stefan Wagenpfeil & Sophie Schne, 2022. "Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    2. Milja Belik & Pinja Jalkanen & Rickard Lundberg & Arttu Reinholm & Larissa Laine & Elina Väisänen & Marika Skön & Paula A. Tähtinen & Lauri Ivaska & Sari H. Pakkanen & Hanni K. Häkkinen & Eeva Ortamo , 2022. "Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    3. Laura Pérez-Alós & Jose Juan Almagro Armenteros & Johannes Roth Madsen & Cecilie Bo Hansen & Ida Jarlhelt & Sebastian Rask Hamm & Line Dam Heftdal & Mia Marie Pries-Heje & Dina Leth Møller & Kamille F, 2022. "Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    4. Georg M. N. Behrens & Joana Barros-Martins & Anne Cossmann & Gema Morillas Ramos & Metodi V. Stankov & Ivan Odak & Alexandra Dopfer-Jablonka & Laura Hetzel & Miriam Köhler & Gwendolyn Patzer & Christo, 2022. "BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33076-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.